In this study, SIRT1 inhibition enhanced FOXK2-induced chemosensitivity to cisplatin via acetylation at K223 of FOXK2, and FOXK2 K223 deacetylation reduced the chemosensitivity of cancer cells to cisplatin (41) (Figure 3). The gene discussed is FOXK2; the disease is cancer.